Involvement of Rho-Kinase Activation in the Pathogenesis of Coronary Hyperconstricting Responses Induced by Drug-Eluting Stents in Patients With Coronary Artery Disease-Reference-Cited by-同舟云学术

Involvement of Rho-Kinase Activation in the Pathogenesis of Coronary Hyperconstricting Responses Induced by Drug-Eluting Stents in Patients With Coronary Artery Disease

Published:2012 Issue:11 Volume:76 Page:2552-2560
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Aizawa Kentaro¹,Yasuda Satoshi¹,Takahashi Jun¹,Takii Toru¹,Kikuchi Yoku¹,Tsuburaya Ryuji¹,Ito Yoshitaka¹,Ito Kenta¹,Nakayama Masaharu¹,Takeda Morihiko¹,Shimokawa Hiroaki¹

Affiliation:

1. Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/76/11/76_CJ-12-0662/_pdf

Reference40 articles.

1. 1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for oronary revascularization. N Engl J Med 2002; 346: 1773–1780.

2. 2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315–1323.

3. 3. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. Engl J Med 2007; 356: 1009–1019.